CIK: 1689394 - Address: C/O Anixa Biosciences, Inc., 3150 Almaden Expressway, Suite 250, San Jose,, CA 95118
5 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/7/24 12:24
6/7/24
ANIXAnixa Biosciences IncDEHealthDrugPharmaceutical PreparationsCatelani MichaelCAOP,COO,CFP152.40062235D
7/21/23 10:06
7/20/23
ANIXAnixa Biosciences IncDEHealthDrugPharmaceutical PreparationsCatelani MichaelCAOP,COO,CFP203.64062627D
4/22/22 09:50
4/21/22
ANIXAnixa Biosciences IncDEHealthDrugPharmaceutical PreparationsCatelani MichaelCAOPP152.66064418D
4/21/22 11:28
4/20/22
ANIXAnixa Biosciences IncDEHealthDrugPharmaceutical PreparationsCatelani MichaelCAOPP62.53032513D
9/19/18 11:47
9/18/18
ITUSItus CorpDEHealthHealthMedical LaboratoriesCatelani MichaelCAOCOO,CFOP104.4502New2D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact